The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

Introduction
============

Percutaneous endoscopic gastrostomy (PEG) tubes are placed for many conditions wherein a patient is unable to intake food orally. The PEG tube was first used in 1980, where an endoscope was used to place a feeding tube into a patient's stomach \[[@REF1]\]. PEG tube use provides more natural nutrition than parenteral feeding and is usually a safe procedure. The most important role of this tube is to provide a route for enteral feeding and hydration and to administer medication in patients who are a potential candidate for inadequate or absent oral intake. PEG feeding is not recommended for short-term use because the 30-day mortality after PEG placement is substantial \[[@REF1],[@REF2]\]. A gastrostomy tube placed endoscopically is usually a better choice than surgical placement \[[@REF3],[@REF4]\]. We describe a case of a patient using PEG tube feeding for almost 20 years with no complications.

Case presentation
=================

 A 59-year-old woman with a past medical history of chronic dysphagia following PEG tube replacement due to thyroid surgery complications approximately 20 years ago presented to the clinic for the establishment of primary care and evaluation for chronic dysphagia as she wished to eat food naturally. She recently moved from Jamaica, where the PEG tube was initially placed soon after the thyroid surgery. Since then, she reported that she has been on PEG tube feeding due to the inability to resume oral feeding. Interestingly, she reported replacing the PEG tube herself through the original track whenever she experienced a tube clog. She reported chewing her food, then pushing it through the tube with a syringe. On examination, we noted a well-healed scar at the base of her neck. The PEG tube was located at the left upper abdomen with no signs of inflammation or drainage at the peristomal area (Figure [1](#FIG1){ref-type="fig"}).

![Image of the abdomen showed replacement PEG tube placed in situ at the left upper quadrant. Blue arrow indicates PEG tube and red arrow indicates the clean and uninfected peristomal area.\
Abbreviations: PEG, percutaneous endoscopic gastrostomy.](cureus-0011-00000005340-i01){#FIG1}

We also noted a laparotomy scar from a previous surgery for intestinal obstruction. The other physical examination findings were not remarkable. Her laboratory evaluations including complete blood count, chemistry panel, and lipid panel with normal findings; the viral serology for Hepatitis B and C were negative. Ultrasonography of the abdomen revealed no significant findings. Recent esophagogastroduodenoscopy revealed scarring in the hypopharynx as well as single diverticulum in the cricopharyngeus without further advancement of the scope (Figure [2](#FIG2){ref-type="fig"}).

![EGD showing scar present in the hypopharynx as well as single diverticulum (blue arrow) in the cricopharyngeus without further advancement of the scope.\
Abbreviations: EGD, esophagogastroduodenoscopy.](cureus-0011-00000005340-i02){#FIG2}

Subsequently, a diatrizoate swallow study revealed the inability of the passage of contrast out of hypopharynx to the esophagus. She was ultimately counseled to depend on PEG feeding as she was maintaining her nutritional status with PEG feeding, and there were no better alternatives considering the potential worse consequences of surgery.

Discussion
==========

PEG feeding plays a significant role in the management of patients with poor voluntary oral intake, mechanical dysphagia, or neurological causes \[[@REF5]\]. The two main goals for PEG placement are a viable route for feeding access and gastric decompression \[[@REF6]\]. The patient should have normal or near-normal gastric and small bowel motility, which are vital prerequisites for PEG tube placement \[[@REF7]\]. The beneficial effects of gastrostomy feeding on morbidity and mortality have been described only in specific subgroups of patients \[[@REF8],[@REF9]\]. The average lifespan of PEG tubes has been reported to be one to two years and is based on tube degradation \[[@REF10]\].

PEG tubes use has been increasing, especially for situations where long-term outcomes are uncertain. Few studies show that while short-term survival rates following PEG tube placement are high (80% to 90%), long-term survival rates are low \[[@REF2]\]. Short-term mortality is commonly attributed to the co-morbidities rather than to the PEG tube itself \[[@REF11]\]. The high long-term mortality rates following the placement of a gastrostomy tube are mostly from severe co-morbidities of the patients in whom tubes are most commonly placed. A US study of mortality rates following PEG tube placement in more than 180,000 patients showed an in-hospital mortality rate of 11% \[[@REF12]\]. There are several factors related to the high risk of death, including advanced patient age, and co-morbidities such as heart failure and renal failure. However, female gender, diabetes mellitus, and paralysis are associated with lower mortality rates.

Several studies report that long-term survival rates are low (approximately 40% at 12 to 18 months, and 20% at three years) \[[@REF3],[@REF8],[@REF13]\]. In the largest study, involving 80,000 patients with gastrostomy tubes, the majority of patients (75%) were older than age 75 \[[@REF14]\]. The most common indications for tube placement were cerebrovascular disease, tumors, fluid and electrolyte disorders, and aspiration pneumonia. Survival rates at one year and three years were 37% and 19%, respectively, and the overall in-hospital mortality rate was 15%.

Approximately 13% to 40% of patients with PEG placement experience minor complications such as maceration due to leakage of gastric contents \[[@REF3],[@REF15]\]. Serious complications have been reported in 0.4% to 4.4% of procedures. In one study, overall mortality from PEG tube placement was below 1% with minor complications occurring in 17% to 24% of patients; major complications requiring surgical intervention occurred in only 6% to 7% \[[@REF16]\].

Conclusions
===========

PEG tube placement has developed into a standard procedure to secure gastric access. Gastrostomy tubes can be placed endoscopically, surgically, and radiologically. There is significant variation in survival after PEG tube insertion. The vulnerable groups are elderly patients with co-morbid illnesses. Despite reports of high short-term survival and low long-term survival, this case presents evidence that PEG tube placement is not only safe but may be used for an indefinite period in patients with mechanical dysphagia without critical illness.
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